MassachusettsAn Act relative to increasing access to epinephrine
What it does
Plain-language analysis is being updated.
Use the official record and source text while enrichment finishes.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed 1st Chamber
- Passed 2nd Chamber
- To Governor
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- May 20New draft substituted, see H5443Latest
- May 20Read second, amended (as recommended by the committee on House Ways and Means)Major
- May 20Rules suspended
- May 20Committee reported that the matter be placed in the Orders of the Day for the next sitting for a second reading with the amendment pending
- May 20Referred to the committee on House Steering, Policy and Scheduling with the amendment pendingMinor
- May 20Committee recommended ought to pass with an amendment, substituting therefor a bill with the same title, see H5443Minor
- 2025
- Dec 4Committee recommended bill ought to pass and referred to the committee on House Ways and MeansMinor
- Oct 16Reported favorably by committee and referred to the committee on Health Care FinancingMinor
- Oct 16New draft of H2367, H2500 and H2503
- Oct 16Reported from the committee on Public HealthIntroduced